Buscar:
Resultado de la búsqueda: 644 ensayos clínicos: (400 ensayos de REEC + 244 ensayos de EudraCT)
Mostrar: Resultados
 N. EudraCT..   Ensayos   Patología   Fases   Reclutamiento   Centros   Fármacos   Fuente   Pdf / Link 
2006-002943-10REPEAT. Repeated ExPosure To Eltrombopag in Adults with Idiopathic Thrombocytopenic Purpura. An Open-label repeat dosing study of eltrombopag olamine (SB-497115-GR) in adult subjects, with chronic idiopathic thrombocytopenic purpura (ITP)TrombopeniaFase IIPor DeterminarEltrombopag, Eltrombopag Eltrombopag SB497115 Tablet, Eltrombopag SB497115 TabletEudraCTLink
2006-000470-78A randomized, double-blind, placebo-controlled phase III study, to evaluate the efficacy, safety and tolerability of eltrombopag olamine (SB-497115-GR), a thrombopoietin receptor agonist, administered for 6 months as oral tablets once daily in adult ... TrombopeniaFASE IIIPor DeterminarEltrombopag, Eltrombopag Eltrombopag SB497115 Tablet, Eltrombopag SB497115 TabletEudraCTLink
2004-000368-28A Double-blind, Randomised, Multicentre, Placebo-controlled, Parallel Group, Dose Ranging Study to Assess the Efficacy, Safety, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist (SB-497115-GR) Administered at 50, 75, and 100 mg to Cance... TrombopeniaFase IIPor DeterminarSB497115 SB497115 TabletEudraCTLink
2004-000367-98A double-blind, randomised, placebo-controlled, parallel group study to investigate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of SB-497115-GR, a thrombopoietin receptor agonist, administered at 30, 50 and 75 mg as oral... TrombopeniaFase IIPor DeterminarSB497115 TabletEudraCTLink